Liver metastasis

Liver metastasis
Diagnosis in short
LM	variable - typically adenocarcinoma
LM DDx	cholangiocarcinoma, hepatocellular carcinoma (esp. pseudoglandular), epithelioid hemangioendothelioma
Site	liver - see liver neoplasms
Clinical history	+/-history of colorectal carcinoma
Prognosis	dependent on stage and primary site, usually poor
Treatment	liver resection if isolated and feasible

A liver metastasis is a malignant metastatic neoplasm in the liver that arose elsewhere. Liver metastases are more common than primary liver neoplasms.

It is also known as metastatic liver disease and hepatic metastasis.

Metastatic disease in general is dealt with in the metastasis article.

General

• Metastases are very common - often from the gastrointestinal tract, e.g. colorectal cancer.
  • Most liver masses in are not biopsied... as a primary lesion is evident.
• Dependent on the extent of disease, CRC metastatic to the liver may be curable with a liver resection.
  • Peritoneal disease, i.e. a malignant peritoneal nodule, in the context of liver metastases does poorly, and is considered a contraindication to liver resection.
• It is important to consider germ cell tumours in the DDx as these may be curable with chemotherapy.
• Clear cell variant of HCC may be misdiagnosed as metastatic clear cell carcinoma.
• Interhepatic cholangiocarcinoma is an adenocarcinoma - it may look like a metastatic lesion.

Gross pathology/radiology

• Multifocal or solitary.
  • Classically multifocal.

• 

  Hepatic metastases (pancreas). (WC)

Microscopic

Features:

• Histologic features are dependent on primary and degree of differentiation.

The classic liver metastasis (colorectal carcinoma):

• Gland forming columnar shaped cells with pseudostratified hyperchromatic cigar-shaped nuclei.

DDx:

• Cholangiocarcinoma.
• Hepatocellular carcinoma, pseudoglandular.
• Epithelioid hemangioendothelioma. (???)

Image

• 

  Liver metastasis - adenocarcinoma. (WC/Nephron)

IHC

• Metastases are typically negative for HepPar-1.
  • HepPar-1 (hepatocytes paraffin antibody 1) - labels hepatocellular mitochondria.

Note:

• If a primary is already established by pathology and the clinical impression is a metastasis, it isn't necessary to do IHC if the morphology of the lesion in the liver is compatible with the established primary.

Sign out

LIVER, PORTION OF SEGMENTS 2 AND 3, RESECTION:
- METASTATIC ADENOCARCINOMA.
-- RESECTION MARGIN CLEARANCE 2 MM.
- LIVER STEATOSIS, MILD.

Micro

The section show liver parenchyma with an invasive adenocarcinoma. The adenocarcinoma has well formed glands with dirty necrosis. The nuclei are appear crowded and have an ellipsoid shape. Focally, zones of necrosis are present. See background liver.

BACKGROUND LIVER (BASED ON H&E ONLY)
Fibrosis: not identified.
Fibrous septa: absent.
Septa with curved contours: absent.
Large droplet steatosis (% of hepatocytes): mild (20%).
Ballooning of hepatocytes: not identified.
Mallory-Denk bodies: not identified.
Portal inflammation: present, mild.
Interface activity: not identified.
Lobular necroinflammation: not identified.
Ducts: present in normal numbers.
Duct injury: not identified.
Ductular reaction: not identified.
Cholestasis: present peritumoural, otherwise absent.
Terminal hepatic venules: present.
Ground glass cells with routine stains: not identified.

See also

• Liver neoplasms.

References

Further reading

• Anders, RA.; Kamel, IR. (May 2007). "Biopsy considerations in the diagnosis of hepatic masses.". Clin Gastroenterol Hepatol 5 (5): 541-4. doi:10.1016/j.cgh.2007.02.028. PMID 17478344.